Duck Virus Enteritis (Duck Plague): Clinical Signs and Diagnosis
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Duck Virus Enteritis (DVE), caused by Anatid herpesvirus 1 (AnHV-1), is a highly contagious and often fatal viral disease affecting waterfowl, characterized by sudden onset, high morbidity, and rapid mortality due to vascular and gastrointestinal damage.
- Clinical signs include depression, photophobia, anorexia, polydipsia, ataxia, serous or hemorrhagic discharge from nares and eyes, and profuse, watery, often blood-tinged diarrhea, leading to rapid dehydration and weight loss.
- Diagnosis relies on a combination of clinical signs, gross necropsy findings (hemorrhagic rings, diphtheritic membranes, liver necrosis), and laboratory confirmation, with PCR and qPCR being primary molecular diagnostic tools for rapid detection of AnHV-1 DNA.
- Differential diagnoses are crucial and include avian cholera, duck hepatitis A virus, Riemerella anatipestifer infection, necrotic enteritis, salmonellosis, and avian influenza, necessitating laboratory differentiation.
- Vaccination is the cornerstone of DVE prevention, utilizing live attenuated vaccines and recombinant vector vaccines; however, emerging variant strains necessitate continuous surveillance and vaccine updates.
- Strict biosecurity measures, including disinfection, quarantine, and avoidance of contact with wild waterfowl, are essential for control, alongside depopulation and thorough cleaning/disinfection in outbreak situations.
What Is Ducks Disease? Defining Duck Virus Enteritis
Duck virus enteritis (DVE), also known as duck plague, is a highly contagious and often fatal viral disease affecting waterfowl. The causative agent is a herpesvirus classified as Anatid herpesvirus 1 (AnHV-1) within the family Herpesviridae, subfamily Alphaherpesvirinae. The disease was first recognized in the Netherlands and subsequently identified in many duck-producing regions worldwide. The term "what is ducks disease" frequently refers to this specific viral syndrome, which is characterized by sudden onset, high morbidity, and rapid mortality in susceptible flocks. The virus causes extensive vascular and gastrointestinal damage, leading to characteristic clinical signs and pathological lesions [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>].
Etiology and Virological Properties
Virion Structure and Genome
AnHV-1 is an enveloped virus with an icosahedral capsid and a double-stranded DNA genome approximately 150-160 kbp in length. Complete genome sequences of several virulent and vaccine strains have been determined, revealing a typical alphaherpesvirus genomic architecture with unique long (UL) and unique short (US) regions flanked by inverted repeats [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. The genome encodes numerous structural and nonstructural proteins. The UL24 protein mediates innate immune evasion by initiating K48/K63-linked polyubiquitination of interferon regulatory factor 7 (IRF7) [<a href="#ref-5">5</a>]. The US3 protein kinase similarly inhibits DNA sensing through phosphorylation of IRF7 [<a href="#ref-6">6</a>]. The UL50 gene product is essential for viral replication and pathogenesis, functioning in nucleotide metabolism [<a href="#ref-7">7</a>]. The LORF4 gene is a late gene that is nonessential for in vitro replication but likely contributes to in vivo fitness [<a href="#ref-8">8</a>]. The viral protein VP26 interacts with the host actin-myosin II network to facilitate viral proliferation [<a href="#ref-9">9</a>].
Variants and Attenuation
Field isolates exhibit variable pathogenicity. A novel variant harboring a deletion in the UL2 gene was characterized and shown to have altered biological properties [<a href="#ref-4">4</a>, <a href="#ref-10">10</a>]. Attenuated vaccine strains often possess combined gene deletions that reduce intestinal pathogenicity and restore gut microbiota balance [<a href="#ref-11">11</a>]. Marker vaccines with deletions in ICP27 have been constructed for DIVA (differentiating infected from vaccinated animals) purposes [<a href="#ref-12">12</a>].
Epidemiology
Host Range and Transmission
DVE primarily affects ducks, geese, and swans within the order Anseriformes. Muscovy ducks (Cairina moschata) and mallards (Anas platyrhynchos) are highly susceptible. The virus can also infect chickens under experimental conditions, though horizontal transmission in chickens is inefficient [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. Wild waterfowl serve as reservoirs and can introduce virus into domestic flocks. Transmission occurs via the fecal-oral route, through contaminated water, feed, or fomites. The virus can be shed in feces and oropharyngeal secretions for several weeks after infection. Vertical transmission is not well documented but remains a theoretical concern given the herpesvirus latency characteristics [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>].
Geographic Distribution
DVE has been reported in Asia, Europe, North America, and Africa. Outbreaks continue to occur even in vaccinated flocks due to the emergence of variant strains or insufficient vaccine coverage. A virulent strain causing outbreak in vaccinated duck flocks was recently isolated in China [<a href="#ref-1">1</a>]. A novel DVEV variant from geese demonstrated altered genomic characteristics and viral shedding patterns [<a href="#ref-15">15</a>]. In Bangladesh, a virulent isolate was fully sequenced, underscoring the global distribution of pathogenic strains [<a href="#ref-2">2</a>].
Clinical Signs
Incubation Period and Forms of Disease
The incubation period ranges from 3 to 7 days under natural conditions. Disease presentation can be peracute, acute, or chronic. Peracute cases die suddenly without premonitory signs. Acute disease is most common and is characterized by depression, photophobia, anorexia, polydipsia, and ataxia. Serous or hemorrhagic discharge from the nares and eyes is frequently observed. The hallmark clinical sign is a profuse, watery, often blood-tinged diarrhea, leading to rapid dehydration and weight loss [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>]. In chronic or recovered birds, emaciation and intermittent diarrhea may persist for weeks.
Ocular and Neurological Signs
Ocular involvement includes conjunctivitis, lacrimation, and in severe cases, corneal opacity or ulceration. Neurological signs such as tremors, opisthotonos, and wing droop have been described in some outbreaks, particularly in ducklings. The degree of neurological involvement is influenced by viral strain and host age [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>].
Morbidity and Mortality
Morbidity often reaches 80-100% in naive flocks, with mortality ranging from 5% to 90% depending on age, immune status, and virus virulence. Adult laying ducks may exhibit a precipitous drop in egg production before other clinical signs become apparent. Infected breeders produce eggs with thin shells and poor hatchability [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>].
Pathological Findings
Gross Lesions
Necropsy findings are dominated by vascular damage and hemorrhages. The most characteristic lesions include hemorrhagic rings and petechiae on the mucosa of the esophagus, pharynx, and intestine. The esophagus and cloaca often contain diphtheritic membranes or pseudomembranes composed of fibrin and necrotic debris. The liver is enlarged, friable, and may exhibit pale, necrotic foci. The spleen is often mottled with hemorrhage or necrosis. Hemorrhages are also found on the heart, gizzard, and in the abdominal fat. The bursa of Fabricius is frequently atrophied or hemorrhagic [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>, <a href="#ref-15">15</a>].
Histopathology
Microscopic examination reveals extensive necrosis of epithelial cells in gastrointestinal mucosa, with intranuclear inclusion bodies (Cowdry type A) characteristic of herpesvirus infection. The liver displays multifocal hepatocyte necrosis and periportal lymphocytic infiltration. Lymphoid organs show depletion of lymphocytes and necrosis of germinal centers. Vascular endothelial damage results in fibrinoid necrosis and thrombosis, explaining the hemorrhagic diathesis [<a href="#ref-10">10</a>, <a href="#ref-16">16</a>].
Diagnosis
Differential Diagnosis
The clinical signs and lesions of DVE overlap with several other waterfowl diseases, making laboratory confirmation essential. Important differentials include:
| Disease | Differentiating Features |
|---|---|
| Avian cholera (Pasteurella multocida) | Septicemia, petechiae on heart and liver, bacteria in blood smear |
| Duck hepatitis A virus | Sudden death in ducklings <6 weeks, hepatic necrosis, no gastrointestinal pseudomembranes |
| Riemerella anatipestifer infection | Serositis, polyserositis, pericarditis, no intranuclear inclusions |
| Necrotic enteritis (Clostridium perfringens) | Focal to diffuse intestinal necrosis with gas, no esophageal lesions |
| Salmonellosis | White diarrhea, hepatosplenomegaly, positive bacterial culture |
| Avian influenza | Respiratory signs, edema of head, pancreatitis, hemagglutination inhibition positive |
A systematic approach to rule out these pathogens using laboratory techniques is recommended [<a href="#ref-1">1</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>].
Laboratory Diagnostic Techniques
Virus Isolation
Isolation of AnHV-1 is performed in embryonated duck eggs (or chicken eggs adapted strains) and primary duck embryo fibroblasts (DEF) or chicken embryo fibroblasts (CEF). Cytopathic effect characterized by rounding, syncytia formation, and intranuclear inclusion bodies develops within 48-72 hours. Virus isolation is considered the gold standard but is time-consuming and requires biosafety level 2 facilities [<a href="#ref-1">1</a>, <a href="#ref-19">19</a>].
Molecular Detection
Polymerase chain reaction (PCR) has become the primary diagnostic tool for rapid detection of DVE. Conventional PCR targeting conserved regions of the UL or US genes is widely used. Real-time quantitative PCR (qPCR) offers increased sensitivity and quantification. Multiplex PCR assays have been developed to simultaneously detect DVE, goose parvovirus, and Muscovy duck parvovirus [<a href="#ref-17">17</a>]. A recombinase polymerase amplification (RPA) assay using real-time fluorescence provides rapid detection within 15-20 minutes with minimal instrumentation [<a href="#ref-20">20</a>]. The multienzyme isothermal rapid amplification (MIRA) platform has been employed to develop MIRA-qPCR and MIRA-lateral flow dipstick (LFD) assays, enabling point-of-care detection [<a href="#ref-21">21</a>]. Visual gene chip technology allows simultaneous detection of seven waterfowl viral pathogens, including DVE, on a single platform [<a href="#ref-18">18</a>].
Serology
Serological diagnosis detects antibodies against AnHV-1 using virus neutralization (VN), enzyme-linked immunosorbent assay (ELISA), or indirect immunofluorescence. VN is specific but labor-intensive. Commercial ELISA kits for DVE are available but may vary in sensitivity. Serology is useful for surveillance and vaccine response evaluation, though it cannot differentiate infected from vaccinated animals unless marker vaccines are used [<a href="#ref-12">12</a>].
Novel Emerging Technologies
CRISPR/Cas9-mediated editing has been employed for constructing recombinant vaccines and for potentially developing diagnostic probes [<a href="#ref-22">22</a>]. Proteomic and untargeted metabolomic approaches have identified host targets and metabolic alterations during infection, which may lead to biomarker-based diagnostics [<a href="#ref-9">9</a>, <a href="#ref-23">23</a>]. RNA sequencing (RNA-seq) has been used to investigate chlorogenic acid intervention in infected duck embryo fibroblasts, revealing transcriptomic changes that could inform diagnostic signatures [<a href="#ref-24">24</a>]. Genomic characterization tools including infectious bacterial artificial chromosome (BAC) cloning allow detailed analysis of virulence determinants [<a href="#ref-3">3</a>].
Diagnostic Workflow
A structured diagnostic algorithm is presented below.
flowchart TD
A["Suspected DVE outbreak"] --> B["Clinical examination and history"]
B --> C{"Typical signs? <br> High mortality, hemorrhagic diarrhea, <br> ocular discharge"}
C -->|"Yes"| D["Necropsy and gross lesion assessment"]
C -->|"No"| E["Consider other differentials"]
D --> F{"Characteristic lesions? <br> Esophageal pseudomembranes, <br> hemorrhagic enteritis, <br> liver necrosis"}
F -->|"Yes"| G["Sample collection: liver, spleen, <br> esophagus, cloacal swabs"]
F -->|"No"| E
G --> H{"Diagnostic method"}
H --> I["Virus isolation in DEF/eggs"]
H --> J["Molecular: PCR, qPCR, RPA, MIRA"]
H --> K["Histopathology: intranuclear inclusions"]
I --> L["Confirmation by immunofluorescence or PCR"]
J --> M["Positive for AnHV-1 DNA"]
K --> N["Positive for Cowdry type A inclusions"]
L --> O["Definitive DVE diagnosis"]
M --> O
N --> O
E --> P["Rule out other pathogens"]Treatment and Control
Antiviral Strategies
No licensed antiviral drug is specifically approved for DVE. Piperazine derivatives were shown to inhibit AnHV-1 infection in vitro by modulating host cytokine responses, suggesting a potential therapeutic avenue [<a href="#ref-25">25</a>]. Poly I:C (polyinosinic-polycytidylic acid) alleviated intestinal injury in infected ducks by inhibiting apoptosis, indicating that immunomodulators may reduce pathology [<a href="#ref-26">26</a>]. These findings remain experimental.
Vaccination
Vaccination is the cornerstone of DVE prevention. Live attenuated vaccines derived from serial passage in chicken embryo fibroblasts or duck embryos are widely used. An Indian strain-based live attenuated vaccine developed in chicken embryo fibroblast cell culture demonstrated safety and efficacy [<a href="#ref-19">19</a>]. Recombinant vector vaccines have been constructed to express immunogenic proteins from duck hepatitis A virus, duck Tembusu virus, goose astrovirus, and influenza virus, providing multivalent protection [<a href="#ref-27">27</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>, <a href="#ref-30">30</a>, <a href="#ref-31">31</a>, <a href="#ref-32">32</a>]. A recombinant DVE virus expressing the OmpH gene of Pasteurella multocida simultaneously protects against duck plague and fowl cholera [<a href="#ref-33">33</a>]. Marker vaccines with deleted virulence genes allow serological differentiation [<a href="#ref-12">12</a>]. However, vaccine breaks due to variant strains necessitate continuous surveillance and vaccine strain updates [<a href="#ref-1">1</a>].
Biosecurity and Control Measures
Control relies on strict biosecurity: quarantine of new birds, disinfection of equipment, and avoidance of contact with wild waterfowl. The virus is susceptible to lipid solvents, formaldehyde, and sodium hypochlorite. In an outbreak, depopulation of affected flocks and thorough cleaning and disinfection are required. Movement restrictions on live birds and eggs should be enforced. Vaccination of at-risk flocks is recommended in endemic areas.
Conclusions
Duck virus enteritis remains a major threat to domestic and wild waterfowl populations worldwide. The clinical presentation and pathological features are largely consistent across strains, but variant viruses with altered virulence and genomic deletions are emerging [<a href="#ref-4">4</a>, <a href="#ref-10">10</a>]. Diagnosis increasingly relies on rapid molecular techniques such as RPA and MIRA, which offer field-deployable options [<a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Continued research into viral pathogenesis, immune evasion mechanisms, and recombinant vaccine development is essential for improved control [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-7">7</a>, <a href="#ref-9">9</a>]. Understanding "what is ducks disease" in the veterinary context requires recognition of DVE as a distinct herpesviral entity with characteristic clinical signs, reliable diagnostic methods, and effective but evolving vaccination strategies.